Revisiting Erythroid Response to Luspatercept in the Phase III BELIEVE Trial Using Real-World Response Criteria - European Medical Journal

This site is intended for healthcare professionals

This content is for healthcare professionals only.

Continue

Revisiting Erythroid Response to Luspatercept in the Phase III BELIEVE Trial Using Real-World Response Criteria

Hematology
Download PDF

The publication of this infographic was supported by Bristol Myers Squibb.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

We’ve noticed you’re accessing
from North/South America.